Research Progress of Design Drugs and Composite Biomaterials in Bone Tissue Engineering
Xinghua Guo,Pan Song,Feng Li,Qihao Yan,Yan Bai,Jincan He,Qishi Che,Hua Cao,Jiao Guo,Zhengquan Su
DOI: https://doi.org/10.2147/IJN.S415666
IF: 7.033
2023-07-02
International Journal of Nanomedicine
Abstract:Xinghua Guo, 1, 2, &ast Pan Song, 1, 2, &ast Feng Li, 1, 2, &ast Qihao Yan, 1, 2, &ast Yan Bai, 3 Jincan He, 3 Qishi Che, 4 Hua Cao, 5 Jiao Guo, 2 Zhengquan Su 1 1 Guangdong Engineering Research Center of Natural Products and New Drugs, Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China; 2 Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China; 3 School of Public Health, Guangdong Pharmaceutical University, Guangzhou, 510310, People's Republic of China; 4 Guangzhou Rainhome Pharm & Tech Co., Ltd, Science City, Guangzhou, 510663, People's Republic of China; 5 School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan, 528458, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhengquan Su, Guangdong Engineering Research Center of Natural Products and New Drugs, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China, Tel +86-20-3935-2067, Fax +86-20-3935-2067, Email Bone, like most organs, has the ability to heal naturally and can be repaired slowly when it is slightly injured. However, in the case of bone defects caused by diseases or large shocks, surgical intervention and treatment of bone substitutes are needed, and drugs are actively matched to promote osteogenesis or prevent infection. Oral administration or injection for systemic therapy is a common way of administration in clinic, although it is not suitable for the long treatment cycle of bone tissue, and the drugs cannot exert the greatest effect or even produce toxic and side effects. In order to solve this problem, the structure or carrier simulating natural bone tissue is constructed to control the loading or release of the preparation with osteogenic potential, thus accelerating the repair of bone defect. Bioactive materials provide potential advantages for bone tissue regeneration, such as physical support, cell coverage and growth factors. In this review, we discuss the application of bone scaffolds with different structural characteristics made of polymers, ceramics and other composite materials in bone regeneration engineering and drug release, and look forward to its prospect. Graphical Keywords: bone scaffold, drug loading, slow release, osteogenesis, biomaterial Graphical Bones are a crucial organ in the human body and provide structural support to facilitate exercise and protect the body's other organs. Bone acts as an important mineral warehouse in the human body that contains a large amount of calcium, phosphorus and other minerals, from which the internal electrolyte level of the human body can be regulated. Additionally, red bone marrow contained in bone is critical to the supply of red blood cells. 1,2 Like most organs, bone tissue cells maintain homeostasis in constant proliferation and apoptosis. However, when encountering severe trauma, malignant tumor, infection and other reasons, the dynamic balance of bone repair will tilt to the bad direction. Every year there are many accidents involving bone caused by traffic accidents, sports, and large-scale machine work. Nearly 50% of people over 50 years old have a bone disease or related disease. 3 Approximately 500,000 patients undergo bone transplants each year in the United States and many more globally. 4 Allogenic, xenogenic and artificial bone transplantation are the most commonly used methods of treatment or repair in clinical practice. Autologous bone grafting is considered the "gold standard" because of the absence of immune response and infection issues during tissue growth. However, patients need to be further injured to obtain materials and must endure long-term postoperative pain. 5 The use of allogeneic or xenogenic bone also needs careful consideration. Although this type of bone has strong bone conductivity and a similar structure, it is difficult to apply due to inflammation, immune response, infectious diseases and other reasons, which also makes the failure rate of allogeneic or xenogeneic bone transplantation higher than that of autologous bone transplantation. 6,7 The main components of bone tissue include inorganic phase and org -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology